{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "35288734",
  "DateCompleted": {
    "Year": "2022",
    "Month": "04",
    "Day": "25"
  },
  "DateRevised": {
    "Year": "2022",
    "Month": "04",
    "Day": "25"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1158/0008-5472.CAN-22-0301"
    ],
    "Journal": {
      "ISSN": "1538-7445",
      "JournalIssue": {
        "Volume": "82",
        "Issue": "6",
        "PubDate": {
          "Year": "2022",
          "Month": "Mar",
          "Day": "15"
        }
      },
      "Title": "Cancer research",
      "ISOAbbreviation": "Cancer Res"
    },
    "ArticleTitle": "Lung Cancer Cell of Origin: Controversy and Clinical Translational Implications.",
    "Pagination": {
      "StartPage": "972",
      "EndPage": "973",
      "MedlinePgn": "972-973"
    },
    "Abstract": {
      "AbstractText": [
        "Identifying the cell(s) of origin for lung cancer including detecting their expansion during \"field cancerization\" and understanding how to therapeutically target them for beneficial chemoprevention is an urgent need. In this issue of Cancer Research, Yin and colleagues provide new and potentially controversial information to this question using Gprc5a knockout genetically engineered mouse models of lung adenocarcinoma. Prior research identified several different cell types including resident lung stem/progenitor such as alveolar type II cells as well as terminally differentiated cells as candidates for the cancer-initiating cell. Yin and colleagues provide new information that the cancer-initiating cell in this model is the bronchioalveolar stem cell. See related article by Yin et al., p. 1025."
      ],
      "CopyrightInformation": "\u00a92022 American Association for Cancer Research."
    },
    "AuthorList": [
      {
        "Identifier": [
          "0000-0002-5537-454X"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas, Texas."
          },
          {
            "Identifier": [],
            "Affiliation": "Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas, Texas."
          },
          {
            "Identifier": [],
            "Affiliation": "Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas."
          }
        ],
        "LastName": "Osborne",
        "ForeName": "Jihan K",
        "Initials": "JK"
      },
      {
        "Identifier": [
          "0000-0002-7776-0767"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas, Texas."
          },
          {
            "Identifier": [],
            "Affiliation": "Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas."
          },
          {
            "Identifier": [],
            "Affiliation": "Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas, Texas."
          },
          {
            "Identifier": [],
            "Affiliation": "Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas."
          }
        ],
        "LastName": "Minna",
        "ForeName": "John D",
        "Initials": "JD"
      }
    ],
    "GrantList": [
      {
        "GrantID": "RP160652",
        "Agency": "CPRIT",
        "Country": ""
      },
      {
        "GrantID": "RR210016",
        "Agency": "CPRIT",
        "Country": ""
      }
    ],
    "PublicationTypeList": [
      "Editorial",
      "Research Support, Non-U.S. Gov't",
      "Comment"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "Cancer Res",
    "NlmUniqueID": "2984705R",
    "ISSNLinking": "0008-5472"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "GPRC5A protein, human"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Receptors, G-Protein-Coupled"
    }
  ],
  "CommentsCorrectionsList": [
    {
      "RefSource": "Cancer Res. 2022 Mar 15;82(6):1025-1037",
      "PMID": "35045987"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Adenocarcinoma of Lung"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Animals"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "pathology"
      ],
      "DescriptorName": "Lung"
    },
    {
      "QualifierName": [
        "pathology"
      ],
      "DescriptorName": "Lung Neoplasms"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Mice"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Receptors, G-Protein-Coupled"
    },
    {
      "QualifierName": [
        "metabolism"
      ],
      "DescriptorName": "Stem Cells"
    }
  ]
}